BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38229083)

  • 1. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
    BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
    Daniel GO; Musa J; Akindigh TM; Shinku F; Shuaibu SI; Kwaghe B; Afolaranmi T; Okpala C; Agbaji O; Sagay A
    Int J Gynaecol Obstet; 2020 Nov; 151(2):253-259. PubMed ID: 32683675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The magnitude and predictors of cervical squamous intraepithelial lesions among women in Enugu, Nigeria: a cross-sectional study of women in a low-resource setting.
    Omeke CA; Enebe JT; Ugwu AI; Onyishi NT; Omeke MC; Enebe NO; Izuka EO; Aniwada EC
    Pan Afr Med J; 2022; 41():130. PubMed ID: 35480408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.
    Habila MA; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
    BMC Womens Health; 2023 Nov; 23(1):640. PubMed ID: 38037005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of opportunistic cervical cancer screening in Nigeria.
    Habila MA; Sagay E; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
    Cancer Causes Control; 2024 Jan; 35(1):9-20. PubMed ID: 37530986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
    Bakari F; Abdul MA; Ahmed SA
    Ann Afr Med; 2017; 16(2):74-80. PubMed ID: 28469121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
    Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
    Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study.
    Okunade KS; Badmos KB; Soibi-Harry AP; Garba SR; Ohazurike EO; Ozonu O; Akanmu AS; Ogunsola FT; Abdulkareem FB; Anorlu RI
    Acta Cytol; 2023; 67(3):248-256. PubMed ID: 36516788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
    Njagi SK; Ngure K; Mwaniki L; Kiptoo M; Mugo NR
    Pan Afr Med J; 2021; 39():44. PubMed ID: 34422167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cytopathological changes in pregnancy: An experience from a low resource setting.
    Rasheed FA; Yakasai IA; Takai IU; Yusuf I; Ibrahim UM
    Ann Afr Med; 2021; 20(3):212-221. PubMed ID: 34558451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
    Massad LS; Xie X; Minkoff HL; Michel KG; D'Souza G; Wang CC; Konkle-Parker D; Ofotokun I; Fischl MA; Rahangdale L; Strickler HD
    Am J Obstet Gynecol; 2021 Oct; 225(4):411.e1-411.e7. PubMed ID: 33957115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria.
    Durowade KA; Osagbemi GK; Salaudeen AG; Musa OI; Akande TM; Babatunde OA; Raji HO; Okesina BS; Fowowe AA; Ibrahim OO; Kolawole OM
    J Prev Med Hyg; 2012 Dec; 53(4):213-9. PubMed ID: 23469591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Risk Factors of Cervical Dysplasia among Human Immunodeficiency Virus Sero-Positive Females on Highly Active Antiretroviral Therapy in Enugu, Southeastern, Nigeria.
    Ogu CO; Achukwu PU; Nkwo PO
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):2987-2994. PubMed ID: 31653145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
    Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
    BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unmet cancer screening need of HIV-positive women in southeastern Nigeria.
    Dim CC; Dim NR; Ezegwui HU; Ikeme AC
    Medscape J Med; 2009; 11(1):19. PubMed ID: 19295940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
    Musa J; Maiga M; Green SJ; Magaji FA; Maryam AJ; Okolo M; Nyam CJ; Cosmas NT; Silas OA; Imade GE; Zheng Y; Joyce BT; Diakite B; Morhason-Bello I; Achenbach CJ; Sagay AS; Ujah IAO; Murphy RL; Hou L; Mehta SD
    BMC Cancer; 2023 Jul; 23(1):683. PubMed ID: 37474918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
    Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
    AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.